![]() | Up a level |
Walls, Gerard M., Oughton, Jamie B., Chalmers, Anthony J., Brown, Sarah, Collinson, Fiona, Forster, Martin D., Franks, Kevin N., Gilbert, Alexandra, Hanna, Gerard G., Hannaway, Nicola, Harrow, Stephen, Haswell, Tom, Hiley, Crispin T., Hinsley, Samantha, Krebs, Matthew, Murden, Geraldine, Phillip, Rachel, Ryan, Anderson J., Salem, Ahmed, Sebag-Montefoire, David, Shaw, Paul, Twelves, Chris J., Walker, Katrina, Young, Robin J., Faivre-Finn, Corinne and Greystoke, Alastair
2020.
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clinical and Translational Radiation Oncology
25
, pp. 61-66.
10.1016/j.ctro.2020.09.006
![]() |
![]() |
Shaw, P., Wills, L., Jones, S., Lamont, H., Morgan, C., Crosby, T. and Radhakrishna, G. 2020. Flip-flop oesophageal movement during radical radiotherapy for oesophageal malignancy. Clinical Oncology 32 (10) , e214-e215. 10.1016/j.clon.2020.06.005 |
![]() |
Middleton, Gary, Brock, Kristian, Savage, Joshua, Mant, Rhys, Summers, Yvonne, Connibear, John, Shah, Riyaz, Ottensmeier, Christian, Shaw, Paul, Lee, Siow-Ming, Popat, Sanjay, Barrie, Colin, Barone, Gloria and Billingham, Lucinda
2020.
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial.
Lancet Respiratory Medicine
8
(9)
, pp. 895-904.
10.1016/S2213-2600(20)30033-3
![]() |
|
Badder, Luned M., Hollins, Andrew J., Herpers, Bram, Yan, Kuan, Ewan, Kenneth B., Thomas, Mairian, Shone, Jennifer R., Badder, Delyth A., Naven, Marc, Ashelford, Kevin E., Hargest, Rachel, Clarke, Alan R., Esdar, Christina, Buchstaller, Hans-Peter, Treherne, J. Mark, Boj, Sylvia, Ramezanpour, Bahar, Wienke, Dirk, Price, Leo S., Shaw, Paul H. and Dale, Trevor C.
2020.
3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
PLoS ONE
15
(8)
, e0235319.
10.1371/journal.pone.0235319
![]() |
![]() |
Shakir, Rebecca, Adams, Richard, Cooper, Rachel, Downing, Amy, Geh, Ian, Gilbert, Duncan, Jacobs, Clare, Jones, Christopher, Lorimer, Cressida, Namelo, Wanangwa C., Sebag-Montefiore, David, Shaw, Paul and Muirhead, Rebecca
2020.
Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma.
International Journal of Radiation Oncology - Biology - Physics
106
(2)
, pp. 329-339.
10.1016/j.ijrobp.2019.10.016
![]() |
![]() |
Daly, C. S., Shaw, Paul, Ordonez, L D, Williams, G T, Quist, J, Grigoriadis, A, Van Es, J H, Clevers, H, Clarke, Alan Richard and Reed, Karen Ruth 2017. Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium. Oncogene 36 (13) 10.1038/onc.2016.342 |
|
Raja, Meera, Zverev, Matthew, Seipel, Katja, Williams, Geraint T., Burnett, Alan Kenneth, Clarke, Alan Richard and Shaw, Paul 2015. Assessment of the in vivo activity of PI3K and MEK inhibitors in genetically defined models of colorectal cancer. Molecular Cancer Therapeutics 14 (10) , pp. 2175-2186. 10.1158/1535-7163.MCT-15-0223 |
![]() |
Tanguay, J. S., Wheeler, P., Button, M., Stevens, R., Shaw, Paul, Brewster, A., Hanna, L. and Lester, J. F. 2014. Limited stage small cell lung cancer (LS SCLC) South East Wales experience. Lung Cancer 88 (Supp 1) , S66. 10.1016/S0169-5002(14)70180-1 |
![]() |
Shaw, Paul and Adams, Richard Alexander 2011. Where now for anti-EGF receptor therapies in colorectal cancer? Expert Review of Anticancer Therapy 11 (10) , pp. 1543-1553. 10.1586/era.11.143 |
![]() |
Shaw, Paul, Maughan, Timothy Stanley and Clarke, Alan Richard 2011. Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apcmin/+ mouse. British Journal of Cancer 105 (5) , pp. 649-657. 10.1038/bjc.2011.291 |
|
Shaw, Paul, Adams, Richard Alexander, Jordan, C. and Crosby, Thomas David Lewis 2007. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. Clinical Oncology 19 (1) , pp. 87-95. 10.1016/j.clon.2006.09.009 |
![]() |
Shaw, Paul and Clarke, Alan Richard 2007. Murine models of intestinal cancer: Recent advances. DNA Repair 6 (10) , pp. 1403-1412. 10.1016/j.dnarep.2007.02.022 |
![]() |
Shaw, Paul and Agrawal, R. 2004. Pleurodesis for malignant pleural effusions. Cochrane Database of Systematic Reviews 2004 (1) , CD002916. 10.1002/14651858.CD002916.pub2 |
![]() |
Shaw, Paul and Marks, A. 2003. Malignant epidural spinal cord compression. European Journal of Palliative Care , pp. 141-144. |
![]() |
Shaw, Paul 2001. The use of NSAIDs in patients with cancer: just how safe is it? European Journal of Palliative Care , pp. 181-185. |
![]() |
McKibben, Pauline E., McCarthy, H. David, Shaw, Paul and Williams, Gareth 1992. Insulin is a specific stimulus to hypothalamic Neuropeptide Y: A comparison of the effects of insulin replacement and food restriction in streptozocin-diabetic rats. Peptides 13 (4) , pp. 721-727. 10.1016/0196-9781(92)90178-6 |
![]() |